Although the clinical activity of abraxane has not been extensively investigated in ovarian carcinoma, the distinct activity of paclitaxel and good results with recurrent metastatic breast cancer patients suggest additional evaluation with this drug is important.
What cancers does Abraxane treat?
This medication is used to treat certain cancers (including breast, lung, and pancreatic cancer). Paclitaxel belongs to a class of drugs known as chemotherapy drugs.
How many cycles of Abraxane can you have?
This treatment is usually given in an outpatient infusion center, allowing the person to go home afterwards. These drugs are repeated every 28 days. This is known as one Cycle. Each cycle may be repeated up to six times (six months), depending upon response, tolerability, and number of cycles prescribed.
How is Abraxane used to treat pancreatic cancer?
ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine. Monitor for neutropenia, which may be severe and result in infection or sepsis.
What is Abraxane + Gemcitabine chemotherapy?
Chemotherapy is a type of medicine that is used to keep cancer cells from growing or to kill cancer cells. Treatment with ABRAXANE and gemcitabine may help control or slow the spread of cancer cells. Your doctor may recommend treatment with ABRAXANE + gemcitabine based on the stage of your cancer and your overall health.
How long does it take to administer Abraxane?
FDA-APPROVED DOSE AND SCHEDULE 1 Administer ABRAXANE followed by gemcitabine weekly for 3 weeks, then 1 week break of each 28-day cycle 2 ABRAXANE is administered intravenously over 30-40 minutes 3 ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine
Can you take Abraxane with paclitaxel?
Cross-hypersensitivity between ABRAXANE and other taxane products has been reported and may include severe reactions such as anaphylaxis. Closely monitor patients with a previous history of hypersensitivity reaction to ABRAXANE with this drug The exposure and toxicity of paclitaxel can be increased in patients with hepatic impairment.
